Literature DB >> 26817652

Anatomical Resection But Not Surgical Margin Width Influence Survival Following Resection for HCC, A Propensity Score Analysis.

Jung-Woo Lee1, Young-Joo Lee2, Kwang-Min Park3, Dae-Wook Hwang3, Jae Hoon Lee3, Ki Byung Song3.   

Abstract

BACKGROUND: The effects of the surgical resection margin on the clinical outcomes in hepatocellular carcinoma (HCC) cases remain controversial. The objective of this study was to further examine this issue.
METHODS: The details of all HCC patients who underwent hepatectomy between December 1999 and December 2009 at the Division of Hepatobiliary and Pancreas Surgery, Asan Medical Center were analyzed retrospectively. We divided 1022 HCC patients into two groups according to the most significant surgical margin length. To overcome any bias due to differences in the distribution of covariates between the two groups, the patients were in a matched 1:1 ratio by propensity score analysis.
RESULTS: A surgical margin ≤1 mm was identified as the most significant surgical margin in both disease-free survival (DFS) and overall survival (OS) (p = 0.008 and p = 0.026, respectively). However, many clinicopathological factors were different between the resection margin ≤1 mm and >1 mm groups. To reduce these different clinicopathological factors, propensity score matching was performed using 21 selected factors. After matching, no significant difference was found in DFS and OS between the two groups (p = 0.688, p = 0.398). In addition, there was no significant difference in the intrahepatic recurrence rate and pattern between the resection margin groups. Except for the preoperative patient's status and tumor stage, significant risk factors in OS were anatomical resection and postoperative morbidity (p = 0.002, p = 0.001).
CONCLUSION: We identified that the widths of the resection margin in resectable hepatocellular carcinoma did not influence the postoperative recurrence rates, overall survival, and recurrence pattern in multivariable analysis as well as propensity score match analysis.

Entities:  

Mesh:

Year:  2016        PMID: 26817652     DOI: 10.1007/s00268-016-3421-5

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  27 in total

1.  Current techniques of liver transection.

Authors:  Ronnie T P Poon
Journal:  HPB (Oxford)       Date:  2007       Impact factor: 3.647

2.  Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group.

Authors:  R B D'Agostino
Journal:  Stat Med       Date:  1998-10-15       Impact factor: 2.373

3.  Significance of resection margin in hepatectomy for hepatocellular carcinoma: A critical reappraisal.

Authors:  R T Poon; S T Fan; I O Ng; J Wong
Journal:  Ann Surg       Date:  2000-04       Impact factor: 12.969

4.  Prognostic significance of surgical margin in hepatocellular carcinoma resection: an analysis of 165 Childs' A patients.

Authors:  G Y Chau; W Y Lui; S H Tsay; K L King; C C Loong; J H Chiu; C W Wu; F K P'eng
Journal:  J Surg Oncol       Date:  1997-10       Impact factor: 3.454

5.  Risk factors and outcome of early recurrence after resection of small hepatocellular carcinomas.

Authors:  Masaki Kaibori; Morihiko Ishizaki; Takamichi Saito; Kosuke Matsui; A-Hon Kwon; Yasuo Kamiyama
Journal:  Am J Surg       Date:  2009-01-29       Impact factor: 2.565

6.  Is less than 5 mm as the narrowest surgical margin width in central resections of hepatocellular carcinoma justified?

Authors:  Kuo-Shyang Jeng; Wen-Juei Jeng; I-Shyan Sheen; Chien-Chu Lin; Cheng-Kuan Lin
Journal:  Am J Surg       Date:  2013-02-04       Impact factor: 2.565

7.  Minor versus major hepatic resection for small hepatocellular carcinoma (HCC) in cirrhotic patients: a 20-year experience.

Authors:  Divya Dahiya; Ting-Jung Wu; Chen-Fang Lee; Kun-Ming Chan; Wei-Chen Lee; Miin-Fun Chen
Journal:  Surgery       Date:  2009-12-11       Impact factor: 3.982

8.  Glissonean pedicle transection method for hepatic resection: a new concept of liver segmentation.

Authors:  K Takasaki
Journal:  J Hepatobiliary Pancreat Surg       Date:  1998

9.  Usefulness of Kelly clamp crushing technique during hepatic resection.

Authors:  K H Kim; S G Lee
Journal:  HPB (Oxford)       Date:  2008       Impact factor: 3.647

10.  Postoperative outcomes in patients with hepatocellular carcinomas resected with exposure of the tumor surface: clinical role of the no-margin resection.

Authors:  Yoichi Matsui; Naoyoshi Terakawa; Sohei Satoi; Masaki Kaibori; Hiroaki Kitade; Soichiro Takai; A-Hon Kwon; Yasuo Kamiyama
Journal:  Arch Surg       Date:  2007-07
View more
  5 in total

1.  Safety margin of radiofrequency ablation for hepatocellular carcinoma: a prospective study using magnetic resonance imaging with superparamagnetic iron oxide.

Authors:  Kuniaki Fukuda; Kensaku Mori; Naoyuki Hasegawa; Katsuhiro Nasu; Kazunori Ishige; Yoshikazu Okamoto; Masanari Shiigai; Masato Abei; Manabu Minami; Ichinosuke Hyodo
Journal:  Jpn J Radiol       Date:  2019-05-17       Impact factor: 2.374

2.  Ideal Surgical Margin to Prevent Early Recurrence After Hepatic Resection for Hepatocellular Carcinoma.

Authors:  Hidetoshi Nitta; Marc-Antoine Allard; Mylène Sebagh; Nicolas Golse; Oriana Ciacio; Gabriella Pittau; Eric Vibert; Antonio Sa Cunha; Daniel Cherqui; Denis Castaing; Henri Bismuth; Hideo Baba; René Adam
Journal:  World J Surg       Date:  2021-01-01       Impact factor: 3.352

3.  Toxicity Profiles of Systemic Therapies for Advanced Hepatocellular Carcinoma: A Systematic Review and Meta-analysis.

Authors:  Christopher D Griffiths; Betty Zhang; Kasia Tywonek; Brandon M Meyers; Pablo E Serrano
Journal:  JAMA Netw Open       Date:  2022-07-01

4.  Recurrence Patterns After Hepatectomy With Very Narrow Resection Margins for Hepatocellular Carcinoma.

Authors:  Chih-Hsien Cheng; Yin Lai; Hao-Chien Hung; Jin-Chiao Lee; Yu-Chao Wang; Tsung-Han Wu; Chen-Fang Lee; Ting-Jung Wu; Hong-Shiue Chou; Kun-Ming Chan; Wei-Chen Lee
Journal:  Front Surg       Date:  2022-07-12

5.  Preoperative survival calculator for resectable hepatocellular carcinoma.

Authors:  Emmanuel Gabriel; Jin Kim; Katherine T Ostapoff; Kristopher Attwood; Sergei Kurenov; Boris Kuvshinoff; Steven N Hochwald; Steven J Nurkin
Journal:  J Gastrointest Oncol       Date:  2018-04
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.